Stellar Pharma (4888) Earnings: Revenue +0.0% YoY at 92 Million Yen, Operating Loss of 245 Million Yen

Stellar Pharma (4888) has released its financial results, reporting revenue up +0.0% year-on-year at 92 million yen. On the profit front, the company posted an operating loss of 245 million yen, an ordinary loss of 228 million yen, and a net loss of 228 million yen, continuing in the red. Earnings per share (EPS) stood at -6.55 yen.

Regarding the financial foundation and valuation metrics, cash and cash equivalents remain at a certain level of 2.78 billion yen, while operating cash flow and free cash flow registered at -330 million yen and -350 million yen respectively. Profitability indicators show an ROE of -27.72% and an ROA of -15.77%, with EBITDA at -720 million yen. Market participants will closely monitor future research and development progress and monetization paths.